3rd ESTRO Forum 2015 S431 that introduce 15%-30% dose differences compared with allwater dosimetry. A TG43 dose rate calculation method is presented that includes silastic and Modulay heterogeneous effects, uses the actual plaque seed configuration, is not restricted to a particular commercial treatment planning system, and does not require purchase of additional software. Materials and Methods: Dose rate is calculated using TG43 formalism: Dose EP (r, θ)= S k Λ[G L (r,θ)/G L (r0,θ0)]g EP (r)F EP (r,θ), with revised radial dose, g EP (r), and anisotropy, F EP (r,θ), functions specific to I-125 or Pd-103 seeds in COMS eye plaques. EP signifies that the functions are specific to COMS eye plaques. g EP (r), is obtained from Monte Carlo data for eye plaques that contain just a single center seed. F EP (r,θ) is obtained by performing a Nelder-Mead Simplex routine to find a least squares solution that minimizes differences between Monte Carlo dose rate and Dose EP (r, θ). Figure: EP method calculation accuracy over the inner sclera surface for 10 mm and 22 mm COMS eye plaques. Dose rate for each curve is normalized to the value at central axis.
Results: TG43 formalism calculations agree with Monte Carlo results, for 10 mm though 22 mm I-125 and Pd-103 eye plaques, to within 2% along and near the plaque central axis and within 4% in the penumbra region for depths ≥ 1 mm. Methods and data for calculating dose rate for COMS plaques with seed model other than I-125 Model 6711 and Pd-103 Model 200 are provided. Since actual seed configurations are used in dose rate calculations, this formalism may also be used to estimate dosimetry for non-standard seed loadings. Conclusions: This manuscript enables the clinical user to perform accurate heterogeneity-corrected dose rate calculations for COMS eye plaques using TG43 formalism in a spreadsheet or commercial treatment planning system that has a TG43 line source geometry function calculation capabilities. require modification owing to the presence of a magnetic field. For this purpose, the calculated differential cross sections (DCS) for electron scattering with and without magnetic field were compared. Materials and Methods: Since water molecules are diamagnetic, they can be expected to partially orient themselves under the influence of an external magnetic field. This is because the overall energy of the water molecules depends on the relative orientation of the molecule with respect to the magnetic field. The orientation of a single water molecule was defined using the Euler angles (α,β,γ), which describe a sequence of rotations around two perpendicular axes. A data set of DCS for elastic scattering and ionisation was computed for various values of the Euler angles from 0° to 360° and incident energies varying between 50 eV and 1 keV. The influence of an external magnetic field was then taken into account by determining the resulting distribution of the fractional number of molecules having a certain orientation. This distribution was used together with the aforementioned data set in order to calculate the mean values of the DCS in presence of a magnetic field.
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Results:
The values of the mean DCS in presence of magnetic field were compared to those with zero field. For 1.5 T, only minor discrepancies of about 7 x10 -8 and 1x10 -9 were found for elastic scattering and ionisation respectively.
Conclusions:
The results show no significant influence of the magnetic field in the range corresponding to MRI-linac devices. Consequently, no changes are necessary in the DCS data used by Monte Carlo simulation codes for dose calculation.
[1] The EMRP is jointly funded by the EMRP participating countries within EURAMET and the European Union. Purpose/Objective: In many cases treatments to the chest wall require complete skin coverage, specifically for patients with stage pT4 disease or with infiltrating carcinoma. Helical Tomotherapy makes it possible to create treatment plans that deliver higher doses to the skin in comparison with other treatments (3D and fixed-gantry IMRT treatments), even without the use of bolus. This work aimed to evaluate, by means of Gafchromic EBT3 films (ISP® Corporation), the skin dose given to patients with chest wall carcinoma undergoing adjuvant tomohelical treatments with and without bolus and also using a virtual bolus, which makes it possible to compensate a potential under-coverage due to breathing motion.
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Materials and Methods:
The study was conducted on a Tomotherapy Hi-Art® System (Accuray®, Sunnyvale, CA). First of all, standard treatment plans (2Gy/fr) were optimized using the TomoTherapy TPS (Version 4.2.2) and delivered to an anthropomorphic phantom (RANDO® Phantom), which had previously been scanned (slice
